CD274 and cancer: Furthermore, using transgenic mouse models, Spranger et al. showed that an active β-catenin signaling in cancer cells contributes to a lack of T cell infiltration in tumor sites and resistance to anti-PD-L1 and/or anti-CTLA4 mAb therapy [199].